Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Performance variance reflects market swings and fund mechanics. This intro highlights how to interpret variation across periods.
27,234 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Southwest Gas missed Q4 earnings by three cents but reaffirmed its 14% annual growth target through 2030, tying the m...
A Switzerland-registered firm launches the $BANK token on Solana, offering on-chain exposure to a professionally mana...
President Trump touts a plan for a government-backed insurance agency to cover Gulf shipping against political risk. ...
BMO Capital Markets cuts Lithium Americas' price target to $4.50, citing 15% capex inflation at Thacker Pass and ongo...
BP weighs UK North Sea exits as part of a sweeping divestment plan, prompting debate over whether the group will stay...
Yorkville America pulled Truth Social crypto ETF filings, signaling a pivot to the 40 Act structure. Analysts debate ...
In 1999, Mark Cuban reportedly earned more from hedging Yahoo shares with a protective collar than from selling Broad...
Investors are watching a split in capital spending: AI-driven data center construction outstrips traditional transpor...
Steve Case frames AI as a major growth engine with job-market risks. The Silicon Valley-to-Main Street debate acceler...
A fresh analysis tests whether a 60-year-old can retire on the Amalfi Coast solely on investment yields, factoring lo...
The MORT ETF offers a double-digit yield, but its payout hinges on the health of its mortgage REIT holdings. This art...